Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar.
The majority of healthy individuals exposed to Mycobacterium tuberculosis will not develop tuberculosis (TB), though many may become latently infected. More precise measurement of the human immune response to M. tuberculosis infection may help us understand this difference and potentially identify those subjects most at risk of developing active disease. Gamma interferon (IFN-gamma) production has been widely used as a proxy marker to study infection and to examine the human immune response to specific M. tuberculosis antigens. It has been suggested that genetically distinct M. tuberculosis strains may invoke different immune responses, although how these differences influence the immune responses and clinical outcome in human tuberculosis is still poorly understood. We therefore evaluated the antigen-specific IFN-gamma production responses in peripheral blood mononuclear cells from two cohorts of subjects recruited in Antananarivo, Madagascar, from 2004 to 2006 and examined the influence of the infecting M. tuberculosis strains on this response. The cohorts were sputum-positive index cases and their household contacts. Clinical strains isolated from the TB patients were typed by spoligotyping. Comparison of the IFN-gamma responses with the spoligotype of the infecting clinical strains showed that "modern" M. tuberculosis strains, like Beijing and Central Asian (CAS) strains, tended to induce lower IFN-gamma responses than "ancient" strains, like East African-Indian (EAI) strains, in index cases and their household contacts. These results suggest that new strains may have evolved to induce a host response different from that of ancient strains. These findings could have important implications in the development of therapeutic and diagnostic strategies.
Rakotosamimanana
Niaina
N
Unité des Mycobactéries, Institut Pasteur de Madagascar, Ambatofotsikely BP 1274, Antananarivo 101, Madagascar.
Raharimanga
Vaomalala
V
Andriamandimby
Soa Fy
SF
Soares
Jean-Louis
JL
Doherty
T Mark
TM
Ratsitorahina
Maherisoa
M
Ramarokoto
Herimanana
H
Zumla
Alimuddin
A
Huggett
Jim
J
Rook
Graham
G
Richard
Vincent
V
Gicquel
Brigitte
B
Rasolofo-Razanamparany
Voahangy
V
D000942:Antigens, Bacterial / Q000097:blood; D003625:Data Collection; D054884:Host-Pathogen Interactions / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis* / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000382:microbiology; D008270:Madagascar; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000302:isolation & purification; D013045:Species Specificity
D000942:Antigens, Bacterial; D007371:Interferon-gamma
PLoS One. 2009 Jun 16;4(6):e5930
19529771
J Clin Microbiol. 2007 Feb;45(2):409-14
17166963
J Clin Microbiol. 2007 Dec;45(12):3891-902
17898156
J Exp Med. 1997 Sep 15;186(6):859-65
9294140
Science. 1999 May 28;284(5419):1520-3
10348738
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3684-9
11891304
Trends Mol Med. 2007 May;13(5):175-82
17418641
J Infect Dis. 2005 Dec 15;192(12):2059-65
16288368
Infect Genet Evol. 2005 Oct;5(4):340-8
16168940
Clin Vaccine Immunol. 2006 Feb;13(2):179-86
16467323
J Infect Dis. 2000 May;181(5):1850-4
10823800
Tuberculosis (Edinb). 2008 May;88(3):244-8
18294915
Curr Opin Pulm Med. 2009 May;15(3):188-200
19387262
J Clin Microbiol. 2005 May;43(5):2070-4
15872224
J Clin Microbiol. 2002 Nov;40(11):3964-9
12409359
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):581-7
19375139
J Immunol. 2005 May 15;174(10):6332-9
15879133
PLoS Pathog. 2008 Mar 28;4(3):e1000034
18369480
J Immunol. 2004 Jun 1;172(11):6938-43
15153513
BMC Microbiol. 2006 Mar 06;6:23
16519816
Infect Immun. 1995 May;63(5):1710-7
7729876
Trends Microbiol. 2002 Jan;10(1):45-52
11755085
J Clin Microbiol. 2008 Apr;46(4):1363-8
18287322
J Clin Microbiol. 1997 Apr;35(4):907-14
9157152
BMC Infect Dis. 2006 Jul 05;6:105
16820066
Nature. 2004 Sep 2;431(7004):84-7
15343336
J Clin Microbiol. 2005 Nov;43(11):5779-81
16272518
Infect Immun. 2006 Dec;74(12):6865-76
16982841
Clin Microbiol Infect. 2007 Feb;13(2):120-128
17328723
Infect Immun. 2008 Jul;76(7):3027-36
18443098
J Infect Dis. 2005 Jul 1;192(1):98-106
15942899
Bull Soc Pathol Exot. 1997;90(5):349-52
9507769
J Infect Dis. 2005 Feb 1;191(3):453-60
15633105
J Biol Chem. 2009 Oct 2;284(40):27101-13
19648652
Immunology. 2004 Aug;112(4):669-73
15270739
Rev Tuberc Pneumol (Paris). 1963 Feb-Mar;27:217-72
14018284
Pediatr Infect Dis J. 2007 Jan;26(1):13-8
17195699
Clin Exp Immunol. 2004 Sep;137(3):460-8
15320894
Tuberculosis (Edinb). 2004;84(5):337-40
15207809
Infect Immun. 2004 Sep;72(9):5511-4
15322056
J Immunol. 2007 Apr 15;178(8):5217-26
17404305
Lancet. 2001 Jun 23;357(9273):2017-21
11438135
J Clin Microbiol. 2001 Apr;39(4):1530-5
11283082
J Clin Microbiol. 1991 Nov;29(11):2578-86
1685494
BMC Infect Dis. 2009 Feb 28;9:23
19250549
Clin Exp Immunol. 2003 Jul;133(1):30-7
12823275
J Clin Microbiol. 2007 May;45(5):1483-90
17360841
J Immunol. 2007 Jul 1;179(1):522-31
17579073
J Infect Dis. 2008 Oct 1;198(7):1037-43
18702608
Nat Rev Microbiol. 2005 Aug;3(8):656-62
16012514
Med Microbiol Immunol. 2009 Feb;198(1):33-7
19034505
Emerg Infect Dis. 2001 Sep-Oct;7(5):880-3
11747703
Ann Inst Pasteur (Paris). 1961 May;100:676-80
13774765
Am J Respir Crit Care Med. 2008 May 15;177(10):1164-70
18276940
J Infect Dis. 2004 Aug 15;190(4):756-66
15272404
Infect Immun. 2002 Oct;70(10):5446-53
12228269
Infect Immun. 1996 Jan;64(1):16-22
8557334
J Immunol Methods. 2005 Mar;298(1-2):129-41
15847803
J Clin Microbiol. 2002 Feb;40(2):704-6
11826002
Int J Tuberc Lung Dis. 2000 Dec;4(12):1181-3
11144463
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2869-73
16477032